American Capital Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.12K Sell
127
-12,623
-99% -$589K ﹤0.01% 379
2025
Q4
$618K Sell
12,750
-1,761
-12% -$87.3K 0.27% 63
2025
Q3
$685K Sell
14,511
-607
-4% -$29.3K 0.32% 56
2025
Q2
$730K Sell
15,118
-103
-0.7% -$5.26K 0.37% 51
2025
Q1
$844K Sell
15,221
-26
-0.2% -$1.41K 0.46% 45
2024
Q4
$735K Sell
15,247
-8,134
-35% -$414K 0.41% 52
2024
Q3
$1.35M Sell
23,381
-43
-0.2% -$2.32K 0.78% 29
2024
Q2
$1.16M Buy
+23,424
New +$1.13M 0.83% 26
2024
Q1
Sell
-23,424
Closed -$1.16M 506
2023
Q4
$1.16M Buy
+23,424
New +$1.15M 0.83% 26

Other funds holding SNY

American Capital Advisory's SNY Position: Q1 2026 in Review

American Capital Advisory reduced its Sanofi (SNY) stake by 99% in Q1 2026, selling an estimated $589K and leaving 127 shares worth $6.12K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

American Capital Advisory first reported a position in SNY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.35M in Q3 2024. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • American Capital Advisory held 127 shares of Sanofi worth $6.12K as of Q1 2026.
  • American Capital Advisory sold 12,623 Sanofi shares in Q1 2026, an estimated $589K.
  • Sanofi made up ﹤0.01% of American Capital Advisory's portfolio in Q1 2026, its #379 holding.
  • American Capital Advisory first reported a position in Sanofi in Q4 2023 and has held it in 9 quarters since.
  • American Capital Advisory's Sanofi position peaked at $1.35M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on American Capital Advisory's 13F filing for Q1 2026, filed 29 Apr 2026.